Cibc Bancorp Usa Inc. Bridge Bio Pharma, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 25,128 shares of BBIO stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,128Holding current value
$1.63 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
433Shares Held
185MCall Options Held
11.2MPut Options Held
1.95M-
Viking Global Investors LP18.6MShares$1.21 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.1 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$863 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$810 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$604 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.64B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...